
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Raquel Viana, Sikhulile Moyo, Daniel G. Amoako, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 679-686
Open Access | Times Cited: 1614
Raquel Viana, Sikhulile Moyo, Daniel G. Amoako, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 679-686
Open Access | Times Cited: 1614
Showing 1-25 of 1614 citing articles:
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas, Nell Saunders, Piet Maes, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 671-675
Open Access | Times Cited: 1456
Delphine Planas, Nell Saunders, Piet Maes, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 671-675
Open Access | Times Cited: 1456
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 654-656
Open Access | Times Cited: 1091
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 654-656
Open Access | Times Cited: 1091
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 977
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 977
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, et al.
Science (2022) Vol. 376, Iss. 6593
Open Access | Times Cited: 844
Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, et al.
Science (2022) Vol. 376, Iss. 6593
Open Access | Times Cited: 844
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 791
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 791
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Sho Iketani, Lihong Liu, Yicheng Guo, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 553-556
Open Access | Times Cited: 790
Sho Iketani, Lihong Liu, Yicheng Guo, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 553-556
Open Access | Times Cited: 790
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
Nicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
The Lancet (2022) Vol. 399, Iss. 10323, pp. 437-446
Open Access | Times Cited: 639
Nicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
The Lancet (2022) Vol. 399, Iss. 10323, pp. 437-446
Open Access | Times Cited: 639
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
Houriiyah Tegally, Monika Moir, Josie Everatt, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1785-1790
Open Access | Times Cited: 609
Houriiyah Tegally, Monika Moir, Josie Everatt, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1785-1790
Open Access | Times Cited: 609
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, et al.
BMJ (2022), pp. e069761-e069761
Open Access | Times Cited: 594
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, et al.
BMJ (2022), pp. e069761-e069761
Open Access | Times Cited: 594
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 549
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 549
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 488-492
Open Access | Times Cited: 546
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 488-492
Open Access | Times Cited: 546
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
Nicole P. Hachmann, Jessica Miller, Ai‐ris Y. Collier, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 1, pp. 86-88
Open Access | Times Cited: 544
Nicole P. Hachmann, Jessica Miller, Ai‐ris Y. Collier, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 1, pp. 86-88
Open Access | Times Cited: 544
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 509
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 509
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 415
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 415
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa
Fareed Abdullah, Jonathan E. Myers, Debashis Basu, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 38-42
Open Access | Times Cited: 390
Fareed Abdullah, Jonathan E. Myers, Debashis Basu, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 38-42
Open Access | Times Cited: 390
Covid-19 Vaccines — Immunity, Variants, Boosters
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 386
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 386
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
Jingyou Yu, Ai‐ris Y. Collier, Marjorie Rowe, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 16, pp. 1579-1580
Open Access | Times Cited: 340
Jingyou Yu, Ai‐ris Y. Collier, Marjorie Rowe, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 16, pp. 1579-1580
Open Access | Times Cited: 340
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 313
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 313
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
Timothée Bruel, Jérôme Hadjadj, Piet Maes, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1297-1302
Open Access | Times Cited: 290
Timothée Bruel, Jérôme Hadjadj, Piet Maes, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1297-1302
Open Access | Times Cited: 290
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
Nature Methods (2023) Vol. 20, Iss. 4, pp. 512-522
Open Access | Times Cited: 288
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
Nature Methods (2023) Vol. 20, Iss. 4, pp. 512-522
Open Access | Times Cited: 288
Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness
Fritz Obermeyer, Martin Jankowiak, Nikolaos Barkas, et al.
Science (2022) Vol. 376, Iss. 6599, pp. 1327-1332
Open Access | Times Cited: 284
Fritz Obermeyer, Martin Jankowiak, Nikolaos Barkas, et al.
Science (2022) Vol. 376, Iss. 6599, pp. 1327-1332
Open Access | Times Cited: 284
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
MacGregor Cox, Thomas P. Peacock, William T. Harvey, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 112-124
Open Access | Times Cited: 272
MacGregor Cox, Thomas P. Peacock, William T. Harvey, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 112-124
Open Access | Times Cited: 272
The changing epidemiology of SARS-CoV-2
Katia Koelle, Michael A. Martin, Rustom Antia, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1116-1121
Open Access | Times Cited: 268
Katia Koelle, Michael A. Martin, Rustom Antia, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1116-1121
Open Access | Times Cited: 268
The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 255
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 255